Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone for Mucositis Pain in Pediatric HSCT (MATCH)
NCT06940570Phase 3Suspended
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2028
- Primary completion
- Aug 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of methadone in mucositis (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Reduction of pain score. Planned start Jan 2028; status: suspended.
02
Drugs
methadone
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT06940570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06940570.